Immunoselection techniques in hematopoietic stem cell transplantation

Giuseppina Li Pira, Simone Biagini, Elisabetta Cicchetti, Pietro Merli, Letizia Pomponia Brescia, Giuseppe Maria Milano, Mauro Montanari

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Hematopoietic Stem Cells Transplantation (HSCT) is an effective treatment for hematological and non-hematological diseases. The main challenge in autologous HSCT is purging of malignant cells to prevent relapse. In allogeneic HSCT graft-versus-host disease (GvHD) and opportunistic infections are frequent complications. Two types of graft manipulation have been introduced: the first one in the autologous context aimed at separating malignant cells from hematopoietic stem cells (HSC), and the second one in allogeneic HSCT aimed at reducing the incidence of GvHD and at accelerating immune reconstitution. Here we describe the manipulations used for cell purging in autologous HSCT or for T Cell Depletion (TCD) and T cell selection in allogeneic HSCT. More complex manipulations, requiring a Good Manufacturing Practice (GMP) facility, are briefly mentioned.

Original languageEnglish
Pages (from-to)356-363
Number of pages8
JournalTransfusion and Apheresis Science
Volume54
Issue number3
DOIs
Publication statusPublished - Jun 1 2016

Fingerprint

Hematopoietic Stem Cell Transplantation
Graft vs Host Disease
T-Lymphocytes
Opportunistic Infections
Hematopoietic Stem Cells
Transplants
Recurrence
Incidence

Keywords

  • Alloreactive cells
  • Cell manipulation
  • Graft-versus-host disease
  • Hematopoietic stem cell
  • Opportunistic infections

ASJC Scopus subject areas

  • Hematology

Cite this

Immunoselection techniques in hematopoietic stem cell transplantation. / Li Pira, Giuseppina; Biagini, Simone; Cicchetti, Elisabetta; Merli, Pietro; Brescia, Letizia Pomponia; Milano, Giuseppe Maria; Montanari, Mauro.

In: Transfusion and Apheresis Science, Vol. 54, No. 3, 01.06.2016, p. 356-363.

Research output: Contribution to journalArticle

@article{a09b9582be6245d4bfede93cf859a888,
title = "Immunoselection techniques in hematopoietic stem cell transplantation",
abstract = "Hematopoietic Stem Cells Transplantation (HSCT) is an effective treatment for hematological and non-hematological diseases. The main challenge in autologous HSCT is purging of malignant cells to prevent relapse. In allogeneic HSCT graft-versus-host disease (GvHD) and opportunistic infections are frequent complications. Two types of graft manipulation have been introduced: the first one in the autologous context aimed at separating malignant cells from hematopoietic stem cells (HSC), and the second one in allogeneic HSCT aimed at reducing the incidence of GvHD and at accelerating immune reconstitution. Here we describe the manipulations used for cell purging in autologous HSCT or for T Cell Depletion (TCD) and T cell selection in allogeneic HSCT. More complex manipulations, requiring a Good Manufacturing Practice (GMP) facility, are briefly mentioned.",
keywords = "Alloreactive cells, Cell manipulation, Graft-versus-host disease, Hematopoietic stem cell, Opportunistic infections",
author = "{Li Pira}, Giuseppina and Simone Biagini and Elisabetta Cicchetti and Pietro Merli and Brescia, {Letizia Pomponia} and Milano, {Giuseppe Maria} and Mauro Montanari",
year = "2016",
month = "6",
day = "1",
doi = "10.1016/j.transci.2016.05.012",
language = "English",
volume = "54",
pages = "356--363",
journal = "Transfusion and Apheresis Science",
issn = "1473-0502",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Immunoselection techniques in hematopoietic stem cell transplantation

AU - Li Pira, Giuseppina

AU - Biagini, Simone

AU - Cicchetti, Elisabetta

AU - Merli, Pietro

AU - Brescia, Letizia Pomponia

AU - Milano, Giuseppe Maria

AU - Montanari, Mauro

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Hematopoietic Stem Cells Transplantation (HSCT) is an effective treatment for hematological and non-hematological diseases. The main challenge in autologous HSCT is purging of malignant cells to prevent relapse. In allogeneic HSCT graft-versus-host disease (GvHD) and opportunistic infections are frequent complications. Two types of graft manipulation have been introduced: the first one in the autologous context aimed at separating malignant cells from hematopoietic stem cells (HSC), and the second one in allogeneic HSCT aimed at reducing the incidence of GvHD and at accelerating immune reconstitution. Here we describe the manipulations used for cell purging in autologous HSCT or for T Cell Depletion (TCD) and T cell selection in allogeneic HSCT. More complex manipulations, requiring a Good Manufacturing Practice (GMP) facility, are briefly mentioned.

AB - Hematopoietic Stem Cells Transplantation (HSCT) is an effective treatment for hematological and non-hematological diseases. The main challenge in autologous HSCT is purging of malignant cells to prevent relapse. In allogeneic HSCT graft-versus-host disease (GvHD) and opportunistic infections are frequent complications. Two types of graft manipulation have been introduced: the first one in the autologous context aimed at separating malignant cells from hematopoietic stem cells (HSC), and the second one in allogeneic HSCT aimed at reducing the incidence of GvHD and at accelerating immune reconstitution. Here we describe the manipulations used for cell purging in autologous HSCT or for T Cell Depletion (TCD) and T cell selection in allogeneic HSCT. More complex manipulations, requiring a Good Manufacturing Practice (GMP) facility, are briefly mentioned.

KW - Alloreactive cells

KW - Cell manipulation

KW - Graft-versus-host disease

KW - Hematopoietic stem cell

KW - Opportunistic infections

UR - http://www.scopus.com/inward/record.url?scp=84969524437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969524437&partnerID=8YFLogxK

U2 - 10.1016/j.transci.2016.05.012

DO - 10.1016/j.transci.2016.05.012

M3 - Article

VL - 54

SP - 356

EP - 363

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

SN - 1473-0502

IS - 3

ER -